Could a daily baby aspirin after delivery heal blood vessels in preeclampsia?

NCT ID NCT03667326

First seen Jan 24, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study tests whether taking a low-dose aspirin (81 mg) daily for three weeks after giving birth can improve blood vessel function in women who had severe preeclampsia. About 100 women will be randomly assigned to receive aspirin or a placebo. The main goal is to see if aspirin helps blood vessels relax and widen better, which could lower the risk of future heart problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

low-dose aspirin (81 mg)

What this could lead to

If it works, this could point toward a simple, low-cost way to help blood vessels recover after preeclampsia and reduce long-term heart risks.

What could go wrong

This is a small, early-phase trial (100 participants) testing a short-term effect on a lab measure (blood vessel function), not on hard outcomes like heart disease. Aspirin may not improve recovery or could cause bleeding.

Conditions

The condition(s) this trial relates to.

preeclampsia severe pre-eclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.